Jagt, Jasmijn Z.
Pothof, Christine D.
Buiter, Hans J. C.
van Limbergen, Johan E.
van Wijk, Michiel P.
Benninga, Marc A.
de Boer, Nanne K. H.
de Meij, Tim G. J.
Article History
Received: 6 November 2020
Accepted: 7 January 2021
First Online: 3 February 2021
Compliance with Ethical Standards
:
: NdB has served as a speaker for AbbVie and MSD and has served as consultant and principal investigator for TEVA Pharma BV and Takeda. He has received a (unrestricted) research grant from Dr. Falk, TEVA Pharma BV, MLDS and Takeda. JvL reports consulting, travel and/or speaker fees and research support from AbbVie, Janssen, Nestlé Health Science, Novalac, Pfizer, Merck, P&G, GSK, Illumina, Otsuka. JJ, CP, HB, MvW, MB, and TdM have nothing to declare.
: The study protocol was in accordance with the ethical guide-lines of the 1975 Declaration of Helsinki and was approved on January 2020 by the local ethics committee of the Amsterdam UMC, location VUmc, under file number 2020.026.
: We have made use of an opt-out consent procedure. Parent(s)/guardian(s) and children (in case of age > 12 years) had the opportunity to file an objection stating that they do not wish for their child/themselves to participate.